SunLink Health Systems, Inc. (SSY)
- Previous Close
0.6200 - Open
0.6200 - Bid 0.6200 x 3200
- Ask 0.9000 x 1800
- Day's Range
0.6200 - 0.6200 - 52 Week Range
0.5400 - 1.1000 - Volume
327 - Avg. Volume
9,382 - Market Cap (intraday)
4.365M - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6000 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 29, 1989
- 1y Target Est
--
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.
www.sunlinkhealth.comRecent News: SSY
Performance Overview: SSY
Trailing total returns as of 5/9/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SSY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SSY
Valuation Measures
Market Cap
4.37M
Enterprise Value
2.97M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.09
Price/Book (mrq)
0.34
Enterprise Value/Revenue
0.06
Enterprise Value/EBITDA
-0.98
Financial Highlights
Profitability and Income Statement
Profit Margin
-14.08%
Return on Assets (ttm)
-13.51%
Return on Equity (ttm)
-25.56%
Revenue (ttm)
46.92M
Net Income Avi to Common (ttm)
-4.16M
Diluted EPS (ttm)
-0.6000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.06M
Total Debt/Equity (mrq)
5.10%
Levered Free Cash Flow (ttm)
-5.34M
Research Analysis: SSY
Company Insights: SSY
SSY does not have Company Insights